NewsRx

Search our medical news database

Herpes

Powerful new genital herpes drug studied at MCG

Published in TB and Outbreaks Week, September 10th, 2002

An experimental drug that may diminish genital herpes outbreaks by helping the immune system find and fight the evasive virus is under study at the Medical College of Georgia.

The immune response modifier called resiquimod is a topical treatment that is more potent than a similar drug used for treating human papillomavirus infections, said Dr. Daron G. Ferris, family medicine physician and investigator.

"We are very excited about this agent's potential because it represents a new class of drugs that has not been previously available for treating genital herpes," he said. Antiviral drugs currently used to treat genital herpes don't eliminate the...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook